// App-Quantinova.ai

: Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients with Resected Ampullary Adenocarcinoma

Researchers

Presenter

  • D.H. Lemmers

Principal Investigators

  • S. Robinson

  • M. Bonds

  • M. Mortimer

  • V.K. Mavroeidis

  • F. Burdio

  • L. Bolm

  • P. Pesseaux

  • U. Wellner

  • B. Ielpo

  • Z. Soonawalla

  • B. Al-Sarireh

  • T. Armstrong

  • A. Alseidi

  • S. White

  • A. Zerbi

  • M.G. Besselink

  • M. Abu Hilal

Medical Centers

  • Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Surgery, the Netherlands

  • Virginia Mason, Surgery, United States

  • Fondazione Poliambulanza, Surgery, Italy

  • Morriston Hospital, Surgery, Swansea, United Kingdom

  • Nouvel Hôpital Civil (NHC), Hepatobiliary and Pancreatic Surgical Unit, France

  • Oxford University Hospitals NHS Foundation Trust, Department of Hepatobiliary and Pancreatic Surgery, Oxford, United Kingdom

  • University Hospital of Southampton NHS Foundation Trust, Surgery, United Kingdom

  • Humanitas Research Hospital, Pancreatic Surgery Unit, Italy

  • Newcastle upon Tyne Hospitals NHS Foundation Trust, Surgery, United Kingdom

  • University Medical Center Schleswig-Holstein, Surgery, Germany

  • Hospital del Mar, Surgery, Spain

Locations

  • Netherlands

  • United Kingdom

  • United States

  • Italy

  • Germany

  • France

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ampullary adenocarcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved